Literature DB >> 3508567

Percutaneous absorption and elimination of the penetration enhancer Azone in humans.

J W Wiechers1, B F Drenth, J H Jonkman, R A de Zeeuw.   

Abstract

The percutaneous absorption and elimination of Azone, a new penetration enhancer, were investigated in humans. The distribution and accumulation of Azone in the skin were studied by means of tape stripping. These studies reveal that pure Azone is poorly absorbed. Furthermore, what little Azone is absorbed appears to be rapidly cleared from the circulation by the kidneys. In order to explain the urinary excretion profile, the formation of at least one metabolite is suggested. No accumulation of Azone in the skin was observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508567     DOI: 10.1023/a:1016439908270

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

Review 1.  Percutaneous absorption.

Authors:  B Idson
Journal:  J Pharm Sci       Date:  1975-06       Impact factor: 3.534

2.  Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin.

Authors:  K Sugibayashi; K Hosoya; Y Morimoto; W I Higuchi
Journal:  J Pharm Pharmacol       Date:  1985-08       Impact factor: 3.765

3.  Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one.

Authors:  R B Stoughton
Journal:  Arch Dermatol       Date:  1982-07
  3 in total
  3 in total

1.  Metabolic conversion of cyoctol during skin passage in humans.

Authors:  R A de Zeeuw; R E Herder; J W Wiechers; B F Drenth
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

2.  Disposition and metabolic profiling of the penetration enhancer Azone. I. In vitro studies: urinary profiles of hamster, rat, monkey, and man.

Authors:  J W Wiechers; B F Drenth; F A Adolfsen; L Prins; R A de Zeeuw
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

3.  New alkyl N,N-dialkyl-substituted amino acetates as transdermal penetration enhancers.

Authors:  O Wong; J Huntington; T Nishihata; J H Rytting
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.